Pedro Henrique Las Casas: How Anticoagulant Agents and Quercetin Influence Cancer Cell Procoagulant Activity
Pedro Henrique Las Casas, Professor at Sorbonne University, Professor of Internal Medicine at Federal University of Minas Gerais (UFMG), Hematologist at Grupo Oncoclínicas, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Cancers, adding:
“Happy to share our latest publication in Cancers with Grigoris Gerotziafas.
‘Enoxaparin, Tinzaparin, and Apixaban Modulate Cancer Cell Procoagulant Activity and Viability: Comparison with Quercetin‘
In this study, we explored how anticoagulant agents and quercetin influence cancer cell procoagulant activity, thrombin generation, and endothelial dysfunction induced by cancer-derived extracellular vesicles.
Our findings provide new insights into the complex interactions between cancer, thrombosis, and the vascular microenvironment.
I am grateful to my colleagues and collaborators for their valuable contributions, and especially proud to be part of the Cancer–Angiogenesis–Thrombosis and Hemostasis (CaVITE) research team at the CRSA PARIS, Inserm Paris UMR_S_938, Sorbonne Université.
Many thanks to all co-authors and collaborators who made this work possible.”
Title: Enoxaparin, Tinzaparin, and Apixaban Modulate Cancer Cell Procoagulant Activity and Viability: Comparison with Quercetin
Authors: Mohammed A. Baghdadi, Pedro Henrique Fernandes do Carmo Las Casas, Elisabeth Mbemba, Aurélie Rousseau, Prakasha Kempaiah, Andrey A. Svistunov, Victoria Bitsadze, Michèle Sabbah, Jawed Fareed, Patrick Van Dreden, Varvara Trachana, Eleftheria Lefkou, Grigoris Gerotziafas

Stay updated on all scientific advances with Hemostasis Today.
-
Sep 5, 2026, 07:35Anticoagulation and Contemporary Secondary Prevention of Thrombosis in Polycythemia Vera
-
Sep 5, 2026, 05:48Punit Mathur: From Leg Pain to Life-Threatening Pulmonary Embolism
-
Sep 5, 2026, 05:44Patrick Stonich: Identifying Missed Signs of Postoperative Pulmonary Embolism in Medical Record Reviews
-
Sep 5, 2026, 05:38Tom Van den Hoek: Warburg Effect Mimicking Refractory Shock in Cancer-Associated PE
-
Sep 5, 2026, 05:11Shinya Goto: Targeted Thrombolysis for High Risk Pulmonary Embolism
-
Sep 5, 2026, 04:56Opportunities for the Next Generation of Hematologists – American Society of Hematology
-
Sep 5, 2026, 04:51Samuel Nwokolo: The Bone Marrow Factory – Anatomy of Blood Production
-
Sep 5, 2026, 04:37Maryam Alaa Alsaid: Diagnostic Puzzle of Sickle Beta Thalassemia
-
Sep 5, 2026, 04:16Key Cardiovascular Insights from ESC Congress